Rchr
J-GLOBAL ID:202101016178776816   Update date: Aug. 08, 2024

Funakoshi Kei

Funakoshi Kei
Research theme for competitive and other funds  (3):
  • 2008 - 2009 ldentification of new target moJecule in autoimmune-mediated polyneuropathy and establ ishment of a disease model
  • 2006 - 2007 Fisher症候群モデル動物の樹立
  • 2005 - 2006 1次感覚ニューロンにおけるb系列ガングリオシドの機能的役割
Papers (36):
  • Kokubun Norito, Tsuchiya Tomohiro, Hamaguchi Mai, Ueda Yoshihiko, Matsuda Hadzki, Ishida Kazuyuki, Funakoshi Kei, Suzuki Keisuke, Yuki Nobuhiro. IgG subclass shifts occurring at acute exacerbations in autoimmune nodopathies. Journal of neurology. 2024
  • Funakoshi Kei, Kokubun Norito, Suzuki Keisuke, Yuki Nobuhiro. Proteinuria is a key to suspect autoimmune nodopathies. European journal of neurology. 2024. e16406
  • Kokubun Norito, Funakoshi Kei, Yuki Nobuhiro. Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?. Journal of the peripheral nervous system : JPNS. 2024
  • Suzuki Keisuke, Suzuki Shiho, Haruyama Yasuo, Funakoshi Kei, Fujita Hiroaki, Sakuramoto Hirotaka, Hamaguchi Mai, Kobashi Gen, Hirata Koichi. Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine. Frontiers in neurology. 2024. 15. 1373574
  • Suzuki Keisuke, Suzuki Shiho, Shiina Tomohiko, Haruyama Yasuo, Fujita Hiroaki, Funakoshi Kei, Hirata Koichi. Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study. Journal of neurology. 2023
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page